Introduction of Chengde Jingfukang Pharmaceutical Group Co., Ltd.

Chengde Jingfukang Pharmaceutical Group Co., Ltd. has experienced nearly 60 years of wind and rain, and has made great progress in the past 30 years of reform and opening up. Under the wise decision of Li, the chairman and general manager at the helm, and under the guidance of strategic planning, the company has developed into a modern large-scale enterprise group integrating science, industry and trade, and has successively entered the top 500 pharmaceutical enterprises in China, the top 50 Chinese medicine enterprises in China and the top 100 taxpayers in China. It is a leading enterprise and key backbone enterprise in the traditional Chinese medicine industry in Hebei Province.

The group company consists of Chengde Jingfukang Pharmaceutical Investment Company, China Medicinal Materials Group Company, Shanghai Fosun Pharmaceutical Group and three shareholders. In addition to the headquarters, the group also owns many old industrial and commercial pharmaceutical enterprises such as Chifeng Long Dan Pharmaceutical Company (Long Dan Pharmaceutical Company), Chifeng Jingfukang Pharmaceutical Co., Ltd., Chengde Jingfukang Pharmaceutical Co., Ltd., Chengde Tianhe Pharmaceutical Co., Ltd. and Chifeng Rongxingtang Medicinal Materials Company. , and has formed an integrated model of Chinese herbal medicine cultivation, Chinese patent medicine research and development, production and sales.

The company has advanced production technology and perfect quality control system, and has production lines of granules, capsules, tablets, oral liquids, soft capsules, tinctures and other dosage forms. The company has computer-controlled extraction production line, Japanese dry granulation production line and German automatic packaging production line. It can produce more than 200 kinds of products, including Jingfukang granules, Yaotongning capsules, Fufang Shiwei tablets and Qinggong Changchun capsules. It is a protected variety of traditional Chinese medicine, and Jingfukang Granule has also been included in the national confidential technical project. Yaotongning Capsule is the first large-scale compound drug to be taken orally by fingerprint control technology. Jingfukang Granule, Yaotongning Capsule and Compound Shiwei Tablet are included in the 20 10 edition of the National Pharmacopoeia, and Jingfukang Granule and Yaotongning Capsule.

The company's marketing network covers 3 1 provinces, municipalities, autonomous regions and municipalities directly under the central government, and is exported to Hong Kong, Macao, Southeast Asia, Europe and the United States, and is deeply trusted and praised by consumers and users.